Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Basil S Lewis

Showing results (141-150 of 240) with videos related to

Pageof 24
Sort By:
American Heart Journal|February 15, 2011
Design and rationale of the radial versus femoral access for coronary intervention (RIVAL) trial: a randomized comparison of radial versus femoral access for coronary angiography or intervention in patients with acute coronary syndromesSanjit S Jolly, Kari Niemelä, Denis Xavier, et al.
European Heart Journal|September 5, 2014
Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROESThomas Vanassche, Mandy N Lauw, John W Eikelboom, et al.
The Journal of Invasive Cardiology|August 9, 2008
Two-year intravascular ultrasound observations in diabetic patients treated with single and double dose sirolimus-eluting stents: results of the double dose diabetes (3D) studySeung-Ho Hur, Junya Ako, Yoshihisa Shimada, et al.
Journal of the American Heart Association|March 13, 2019
Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y<sub>12</sub> Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO TrialFrancesco Franchi, Stefan K James, Tatevik Ghukasyan Lakic, et al.
Clinical Cardiology|March 26, 2019
Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trialPatricia O Guimarães, Sean D Pokorney, Renato D Lopes, et al.
European Heart Journal. Acute Cardiovascular Care|November 14, 2013
Duration of eptifibatide infusion after percutaneous coronary intervention and outcomes among high-risk patients with non-ST-segment elevation acute coronary syndrome: insights from EARLY ACSConnie N Hess, Phillip J Schulte, L Kristin Newby, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 13, 2018
Reasons for disparity in statin adherence rates between clinical trials and real-world observations: a reviewAlexander Vonbank, Heinz Drexel, Stefan Agewall, et al.
The New England Journal of Medicine|November 17, 2020
Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent PericarditisAllan L Klein, Massimo Imazio, Paul Cremer, et al.
American Heart Journal|September 11, 2013
Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: insights from the PLATelet inhibition and patient outcomes (PLATO) trialEmmanouil S Brilakis, Claes Held, Bernhard Meier, et al.
Heart (British Cardiac Society)|October 31, 2022
Transition to rilonacept monotherapy from oral therapies in patients with recurrent pericarditisAntonio Brucato, Alistair Wheeler, Sushil Allen Luis, et al.
Pageof 24

Showing results (141-150 of 240) with videos related to

Sort By:
Pageof 24
American Heart Journal|February 15, 2011
Design and rationale of the radial versus femoral access for coronary intervention (RIVAL) trial: a randomized comparison of radial versus femoral access for coronary angiography or intervention in patients with acute coronary syndromesSanjit S Jolly, Kari Niemelä, Denis Xavier, et al.
European Heart Journal|September 5, 2014
Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROESThomas Vanassche, Mandy N Lauw, John W Eikelboom, et al.
The Journal of Invasive Cardiology|August 9, 2008
Two-year intravascular ultrasound observations in diabetic patients treated with single and double dose sirolimus-eluting stents: results of the double dose diabetes (3D) studySeung-Ho Hur, Junya Ako, Yoshihisa Shimada, et al.
Journal of the American Heart Association|March 13, 2019
Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y<sub>12</sub> Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO TrialFrancesco Franchi, Stefan K James, Tatevik Ghukasyan Lakic, et al.
Clinical Cardiology|March 26, 2019
Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trialPatricia O Guimarães, Sean D Pokorney, Renato D Lopes, et al.
European Heart Journal. Acute Cardiovascular Care|November 14, 2013
Duration of eptifibatide infusion after percutaneous coronary intervention and outcomes among high-risk patients with non-ST-segment elevation acute coronary syndrome: insights from EARLY ACSConnie N Hess, Phillip J Schulte, L Kristin Newby, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 13, 2018
Reasons for disparity in statin adherence rates between clinical trials and real-world observations: a reviewAlexander Vonbank, Heinz Drexel, Stefan Agewall, et al.
The New England Journal of Medicine|November 17, 2020
Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent PericarditisAllan L Klein, Massimo Imazio, Paul Cremer, et al.
American Heart Journal|September 11, 2013
Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: insights from the PLATelet inhibition and patient outcomes (PLATO) trialEmmanouil S Brilakis, Claes Held, Bernhard Meier, et al.
Heart (British Cardiac Society)|October 31, 2022
Transition to rilonacept monotherapy from oral therapies in patients with recurrent pericarditisAntonio Brucato, Alistair Wheeler, Sushil Allen Luis, et al.
Pageof 24